• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ki-67对浅表性膀胱癌复发和进展的预后价值。

Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer.

作者信息

Asakura T, Takano Y, Iki M, Suwa Y, Noguchi S, Kubota Y, Masuda M

机构信息

Department of Urology, Yokohama City University School of Medicine, Japan.

出版信息

J Urol. 1997 Aug;158(2):385-8.

PMID:9224308
Abstract

PURPOSE

We retrospectively reviewed 104 cases of superficial bladder cancer to ascertain whether the Ki-67 labeling index predicts recurrence and progression.

MATERIALS AND METHODS

Archival specimens from superficial bladder cancer cases were immunostained with Ki-67.

RESULTS

The recurrence rate was significantly higher in cases with a Ki-67 labeling index of 5.35 or greater than in those with a value less than 5.35 (p < 0.001). The recurrence rate at 2 years was 70% in cases with a Ki-67 labeling index of 5.35 or greater and 22% in those with an index less than 5.35 (p < 0.001). Using multivariate analysis the index predicted recurrence of bladder cancer (p < 0.005). Median Ki-67 labeling index in cases with progression was significantly higher than in those without progression (p < 0.01).

CONCLUSIONS

The Ki-67 labeling index is an independent predictive factor for recurrence of superficial bladder cancer.

摘要

目的

我们回顾性分析了104例浅表性膀胱癌病例,以确定Ki-67标记指数是否可预测复发和进展情况。

材料与方法

对浅表性膀胱癌病例的存档标本进行Ki-67免疫染色。

结果

Ki-67标记指数为5.35或更高的病例的复发率显著高于该指数低于5.35的病例(p < 0.001)。Ki-67标记指数为5.35或更高的病例2年复发率为70%,而指数低于5.35的病例为22%(p < 0.001)。多因素分析显示该指数可预测膀胱癌复发(p < 0.005)。进展病例的Ki-67标记指数中位数显著高于无进展病例(p < 0.01)。

结论

Ki-67标记指数是浅表性膀胱癌复发的独立预测因素。

相似文献

1
Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer.Ki-67对浅表性膀胱癌复发和进展的预后价值。
J Urol. 1997 Aug;158(2):385-8.
2
Prospective evaluation of Ki-67 labeling in predicting the recurrence and progression of superficial bladder transitional cell carcinoma.Ki-67标记物在预测浅表性膀胱移行细胞癌复发和进展中的前瞻性评估
Eur Urol. 2001 Aug;40(2):169-75. doi: 10.1159/000049768.
3
Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.p53、bcl-2和Ki-67在高危浅表性膀胱癌中的预后意义
Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.
4
Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.增殖细胞核仁组成区嗜银蛋白对浅表性膀胱肿瘤局部复发具有预测价值。
J Urol. 1999 Jul;162(1):63-8. doi: 10.1097/00005392-199907000-00016.
5
Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.p27(Kip1)和细胞周期蛋白E蛋白水平的降低与浅表性膀胱癌向浸润性膀胱癌的进展相关。
Br J Cancer. 2001 May 4;84(9):1242-51. doi: 10.1054/bjoc.2000.1736.
6
Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.CK20 和 Ki-67 免疫组化联合分析预测 pT1 尿路上皮膀胱癌的复发、进展和癌症特异性生存。
Eur Urol. 2014 Jan;65(1):218-26. doi: 10.1016/j.eururo.2012.05.033. Epub 2012 May 19.
7
Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.评估缺氧诱导因子1α过表达作为浅表性膀胱尿路上皮癌肿瘤复发和进展预测指标的研究
BJU Int. 2005 Feb;95(3):425-31. doi: 10.1111/j.1464-410X.2005.05314.x.
8
Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.卡介苗膀胱灌注治疗浅表性膀胱肿瘤患者中p53、p21WAF1/CIP1和Ki-67表达的相关性及预后意义
J Urol. 1999 Mar;161(3):792-8.
9
E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.E-钙黏蛋白免疫反应性与膀胱微浸润性移行细胞癌的复发和进展相关。
Oncol Rep. 2005 Oct;14(4):1065-70.
10
Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.通过溴脱氧尿苷标记指数评估的增殖活性在确定浅表性中度恶性膀胱肿瘤复发预测因素中的作用。
J Urol. 1996 Jul;156(1):63-9.

引用本文的文献

1
Predicting response to bacillus Calmette-Guerin in high-risk non-muscle invasive bladder cancer.预测高危非肌层浸润性膀胱癌对卡介苗的反应
Transl Cancer Res. 2024 Nov 30;13(11):6489-6502. doi: 10.21037/tcr-24-180. Epub 2024 Jul 30.
2
Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis.Ki-67在非肌层浸润性膀胱癌患者中的意义:一项系统评价和荟萃分析。
Oncotarget. 2017 Oct 13;8(59):100614-100630. doi: 10.18632/oncotarget.21899. eCollection 2017 Nov 21.
3
High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
高Ki-67免疫组化反应性与膀胱癌预后不良相关:一项纳入13053例患者的综合荟萃分析。
Medicine (Baltimore). 2016 Apr;95(15):e3337. doi: 10.1097/MD.0000000000003337.
4
Prognostic value of cell-cycle regulation biomarkers in bladder cancer.细胞周期调控生物标志物在膀胱癌中的预后价值。
Semin Oncol. 2012 Oct;39(5):524-33. doi: 10.1053/j.seminoncol.2012.08.008.
5
Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model.在原位膀胱癌模型中,膀胱内联合使用丝裂霉素C和卡介苗治疗增强抗肿瘤效果。
Oncol Lett. 2011 Jan;2(1):13-19. doi: 10.3892/ol.2010.217. Epub 2010 Nov 23.
6
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review.复发性膀胱移行细胞癌:一例混合型巢状变异型病例报告及文献综述。
Can Urol Assoc J. 2012 Apr;6(2):E57-60. doi: 10.5489/cuaj.11094.
7
P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder.膀胱移行细胞癌中P27(Kip1)和Ki-67表达分析
Urol Res. 2003 Dec;31(6):397-401. doi: 10.1007/s00240-003-0356-8. Epub 2003 Sep 27.
8
The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.增殖细胞核抗原、Ki-67和核仁组织区在膀胱移行细胞癌中的预后价值
Int Urol Nephrol. 2002;33(1):59-66. doi: 10.1023/a:1014452902976.
9
Bladder tumor markers: need, nature and application. 1. Nucleus-based markers.膀胱肿瘤标志物:需求、性质及应用。1. 基于细胞核的标志物。
Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(4):221-7. doi: 10.1007/BF01901608.